UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma

Analytical chemistry (Washington), 2017-01, Vol.89 (1), p.656-665

2017

Volltextzugriff (PDF)

De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy

Autophagy, 2020-06, Vol.16 (6), p.1044-1060

2020

Volltextzugriff (PDF)

Presence of human breast cancer xenograft changes the diurnal profile of amino acids in mice

Scientific reports, 2022-01, Vol.12 (1), p.1008-1008, Article 1008

2022

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4152-4161

2005

Volltextzugriff (PDF)

Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Molecular cancer therapeutics, 2016-06, Vol.15 (6), p.1412-1424

2016

Volltextzugriff (PDF)

Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulation

Metabolomics, 2020-04, Vol.16 (4), p.50, Article 50

2020

Volltextzugriff (PDF)

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Molecular cancer therapeutics, 2017-10, Vol.16 (10), p.2315-2323

2017

Volltextzugriff (PDF)

Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications

Cells (Basel, Switzerland), 2022-10, Vol.11 (20), p.3286

2022

Volltextzugriff (PDF)

Inter-Laboratory Robustness of Next-Generation Bile Acid Study in Mice and Humans: International Ring Trial Involving 12 Laboratories

The journal of applied laboratory medicine, 2016-09, Vol.1 (2), p.129-142

2016

Volltextzugriff (PDF)

A validated liquid chromatographic–tandem mass spectroscopy method for the quantification of abiraterone acetate and abiraterone in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006-11, Vol.843 (2), p.262-267

2006

Volltextzugriff (PDF)

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma

Investigational new drugs, 2012-02, Vol.30 (1), p.341-349

2012

Volltextzugriff (PDF)

Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models

Cancer chemotherapy and pharmacology, 2018-11, Vol.82 (5), p.911-912

2018

Volltextzugriff (PDF)

Inter-laboratory reproducibility of a targeted metabolomics platform for analysis of human serum and plasma

Analytical chemistry (Washington), 2016-12, Vol.89 (1), p.656-665

2016

Volltextzugriff (PDF)

Validation of liquid chromatography assay for the quantitation of ( Z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003-02, Vol.785 (1), p.175-186

2003

Volltextzugriff (PDF)

Abstract 3517: Changes in plasma components of β-oxidation as a pharmacodynamic (PD) biomarker of PI3K inhibition by GDC-0941, a potent, pan-inhibitor of Class I phosphatidyl-inositol-3-kinase (PI3K)

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3517-3517

2013

Volltextzugriff (PDF)

Abstract B190: Pharmacokinetics of the AKT inhibitor CCT128930 from dried blood spots sampled from caudal bleeding compared with conventional cardiac puncture

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.B190-B190

2011

Volltextzugriff (PDF)

An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models

Cancer chemotherapy and pharmacology, 2008-10, Vol.62 (5), p.769-778

2008

Volltextzugriff (PDF)

Azoreductase and nitroreductase activity of bacteria in feces from patients with an ileal reservoir

Digestive diseases and sciences, 1997, Vol.42 (1), p.133-136

1997

Volltextzugriff (PDF)

Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of the novel anticancer agent 17-DMAG in human plasma

Rapid communications in mass spectrometry, 2006-01, Vol.20 (19), p.2845-2850

2006

Volltextzugriff (PDF)

Early discontinuation of non-nucleoside reverse transcriptase inhibitors and protease inhibitors in a HIV-infected population: A pharmacoepidemiological validation study

Asad, Shaneena Yasmin

2005

Volltextzugriff (PDF)

Oral mucositis & oral health related quality of life in women undergoing chemotherapy for breast cancer in Karachi, Pakistan: A multicenter hospital based cross-sectional study

PloS one, 2024-04, Vol.19 (4), p.e0295456-e0295456

2024

Volltextzugriff (PDF)

Sodium nitroprusside application improves morphological and physiological attributes of soybean (Glycine max L.) under salinity stress

PloS one, 2021-04, Vol.16 (4), p.e0248207-e0248207

2021

Volltextzugriff (PDF)

Engineering of QbD driven and ultrasonically shaped lyotropic liquid crystalline nanoparticles for Apigenin in the management of skin cancer

European journal of pharmaceutics and biopharmaceutics, 2022-11, Vol.180, p.269-280

2022

Volltextzugriff (PDF)

Insights into Pharmacological Potential of Apigenin through Various Pathways on a Nanoplatform in Multitude of Diseases

Current pharmaceutical design, 2023-01, Vol.29 (17), p.1326

2023

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(79)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma

De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy

International Ring Trial of a High Resolution Targeted Metabolomics and Lipidomics Platform for Serum and Plasma Analysis

Presence of human breast cancer xenograft changes the diurnal profile of amino acids in mice

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies

Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulation

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications

Inter-Laboratory Robustness of Next-Generation Bile Acid Study in Mice and Humans: International Ring Trial Involving 12 Laboratories

A validated liquid chromatographic–tandem mass spectroscopy method for the quantification of abiraterone acetate and abiraterone in human plasma

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma

Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models

Inter-laboratory reproducibility of a targeted metabolomics platform for analysis of human serum and plasma

Validation of liquid chromatography assay for the quantitation of ( Z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial

Abstract 3517: Changes in plasma components of β-oxidation as a pharmacodynamic (PD) biomarker of PI3K inhibition by GDC-0941, a potent, pan-inhibitor of Class I phosphatidyl-inositol-3-kinase (PI3K)

Abstract B190: Pharmacokinetics of the AKT inhibitor CCT128930 from dried blood spots sampled from caudal bleeding compared with conventional cardiac puncture

An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models

Azoreductase and nitroreductase activity of bacteria in feces from patients with an ileal reservoir

Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of the novel anticancer agent 17-DMAG in human plasma

Early discontinuation of non-nucleoside reverse transcriptase inhibitors and protease inhibitors in a HIV-infected population: A pharmacoepidemiological validation study

Oral mucositis & oral health related quality of life in women undergoing chemotherapy for breast cancer in Karachi, Pakistan: A multicenter hospital based cross-sectional study

Sodium nitroprusside application improves morphological and physiological attributes of soybean (Glycine max L.) under salinity stress

Engineering of QbD driven and ultrasonically shaped lyotropic liquid crystalline nanoparticles for Apigenin in the management of skin cancer

Insights into Pharmacological Potential of Apigenin through Various Pathways on a Nanoplatform in Multitude of Diseases

Suchergebnisse filtern